Azzad Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Azzad Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-129,595	Closed	-$1.09M	–	292
2017 Q2	$1.09M	Buy	129,595 +2,535	+2%	+$20.6K	0.39%	88
2017 Q1	$1.02M	Buy	127,060 +29,040	+30%	+$251K	0.38%	97
2016 Q4	$888K	Sell	98,020 -985	-1%	-$9.17K	0.37%	101
2016 Q3	$919K	Buy	99,005 +16,440	+20%	+$157K	0.38%	104
2016 Q2	$846K	Buy	82,565 +15,305	+23%	+$140K	0.36%	103
2016 Q1	$608K	Sell	67,260 -13,670	-17%	-$122K	0.27%	147
2015 Q4	$749K	Buy	80,930 +1,665	+2%	+$18.2K	0.36%	109
2015 Q3	$1.01M	Buy	79,265 +7,080	+10%	+$87.9K	0.54%	64
2015 Q2	$799K	Buy	72,185 +31,280	+76%	+$345K	0.4%	105
2015 Q1	$467K	Buy	40,905 +3,155	+8%	+$33.5K	0.22%	174
2014 Q4	$381K	Buy	+37,750	New	+$397K	0.2%	197

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Azzad Asset Management's RDY Position: Q3 2017 in Review

Azzad Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2017, closing a stake of 129,595 shares — an estimated $1.09M sold.

Azzad Asset Management first reported a position in RDY in Q4 2014 and held it in 11 quarters. The position peaked at $1.09M in Q2 2017. 118 funds tracked by Wall St. Rank hold RDY as of Q3 2017.

Azzad Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2017 after selling out during the quarter.
Azzad Asset Management sold 129,595 Dr. Reddy's Laboratories shares in Q3 2017, an estimated $1.09M.
Azzad Asset Management first reported a position in Dr. Reddy's Laboratories in Q4 2014 and held it in 11 quarters.
Azzad Asset Management's Dr. Reddy's Laboratories position peaked at $1.09M in Q2 2017.
118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2017.

Based on Azzad Asset Management's 13F filing for Q3 2017, filed 3 Apr 2024.